Page 75 - 《南京医科大学学报(自然科学版)》2026年第3期
P. 75

第46卷第3期 杨 燕,胡琴琴,刘 裔,等. 利福平和利福布汀对rpoB基因突变而表型敏感的结核菌耐药性研究[J].
                  2026年3月                     南京医科大学学报(自然科学版),2026,46(3):375-383                        ·383 ·


                    Microbiol Spectr,2024,12(1):e0163123               rpoB gene mutation and clinical outcomes of Staphylococ⁃
               [19]WEI L Q,CHEN J,DENG Z,et al. Genetic diversity and  cus species isolates from prosthetic joint infections in Re⁃
                    transmission pattern of multidrug ⁃ resistant tuberculosis  public of Korea[J]. J Glob Antimicrob Resist,2022,28:
                    based on whole⁃genome sequencing in Wuhan,China[J].  43-48
                    Front Public Health,2025,13:1442987          [30]RIGDEN D J. The histidine phosphatase superfamily:
               [20]CASTRO ⁃ RODRIGUEZ B,ESPINOZA ⁃ ANDRADE S,          Structure and function[J]. Biochem J,2008,409(2):
                    FRANCO⁃SOTOMAYOR G,et al. A first insight into tu⁃  333-348
                    berculosis transmission at the border of Ecuador and Co⁃  [31]METCALFE R D,MARTINEZ FIESCO J A,BONET ⁃
                    lombia:a retrospective study of the population structure  PONCE L,et al. Structure and regulation of full⁃length hu⁃
                    of Mycobacterium tuberculosis in Esmeraldas province[J].  man leucine⁃rich repeat kinase 1[J]. Nat Commun,2023,
                    Front Public Health,2024,12:1343350                14(1):4797
               [21]LE HANG N T,HIJIKATA M,MAEDA S,et al. Whole ge⁃  [32]XU G,LIU H C,JIA X D,et al. Mechanisms and detec⁃
                    nome sequencing,analyses of drug resistance⁃conferring  tion methods of Mycobacterium tuberculosis rifampicin
                    mutations,and correlation with transmission of Mycobacte⁃  resistance:the phenomenon of drug resistance is com⁃

                    rium tuberculosis carrying katG⁃S315T in Hanoi,Viet⁃  plex[J]. Tuberculosis(Edinb),2021,128:102083
                    nam[J]. Sci Rep,2019,9:15354                 [33]GOOSSENS S N,SAMPSON S L,VAN RIE A. Mecha⁃
               [22]CHEN L,GAN X,LI N N,et al. rpoB gene mutation pro⁃  nisms of drug⁃induced tolerance in Mycobacterium tuber⁃
                    file in rifampicin ⁃ resistant Mycobacterium tuberculosis  culosis[J]. Clin Microbiol Rev,2020,34(1):e00141-20
                    clinical isolates from Guizhou,one of the highest inci⁃  [34]FLOSS H G,YU T W. Rifamycin⁃mode of action,resis⁃
                    dence rate regions in China[J]. J Antimicrob Chemother,  tance,and biosynthesis[J]. Chem Rev,2005,105(2):
                    2010,65(6):1299-1301                               621-632
               [23]QADIR M,TAHSEEN S,MCHUGH T D,et al. Profiling  [35]TREBOSC V,KEMMER C,LOCIURO S,et al. Rifabutin
                    and identification of novel rpoB mutations in rifampicin⁃  for infusion(BV100)for the treatment of severe carbapen⁃
                    resistant Mycobacterium tuberculosis clinical isolates from  em⁃resistant Acinetobacter baumannii infections[J]. Drug
                    Pakistan[J]. J Infect Chemother,2021,27(11):1578-  Discov Today,2021,26(9):2099-2104
                    1583                                         [36]BURMAN W J,GALLICANO K,PELOQUIN C. Compara⁃
               [24]ZENG M C,JIA Q J,TANG L M. rpoB gene mutations in   tive pharmacokinetics and pharmacodynamics of the rifa⁃
                    rifampin ⁃ resistant Mycobacterium tuberculosis isolates  mycin antibacterials[J]. Clin Pharmacokinet,2001,40
                    from rural areas of Zhejiang,China[J]. J Int Med Res,  (5):327-341
                    2021,49(3):300060521997596                   [37]NAHID P,MASE S R,MIGLIORI G B,et al. Treatment of
               [25]LEAVITT S V,JACOBSON K R,RAGAN E J,et al. De⁃       drug⁃resistanttuberculosis.anofficialATS/CDC/ERS/IDSA
                    centralized care for rifampin⁃resistant tuberculosis,west⁃  clinical practice guideline[J]. Am J Respir Crit Care
                    ern cape,South Africa[J]. Emerg Infect Dis,2021,27  Med,2019,200(10):e93-e142
                   (3):728-739                                   [38]LIN W H,LEE W T,TSAI H Y,et al. Disputed rpoB mu⁃
               [26]SADOVSKA D,NODIEVA A,POLE I,et al. Discordance      tations in Mycobacterium tuberculosis and tuberculosis
                    between phenotypic and WGS ⁃ based drug susceptibility  treatment outcomes[J]. Antimicrob Agents Chemother,
                    testing results for some anti ⁃ tuberculosis drugs:a snap⁃  2021,65(7):e0157320
                    shot study of paired Mycobacterium tuberculosis isolates  [39]李  广,李力韬,崔  旭,等. 核酸检测指导个体化耐药
                    with small genetic distance[J]. Infect Drug Resist,2024,  脊柱结核治疗[J]. 中国矫形外科杂志,2021,29(1):
                    17:3289-3307                                       37-41
               [27]LI M C,WANG X Y,XIAO T Y,et al. rpoB mutations are  LI G,LI L T,CUI X,et al. Nucleic acid testing guides in⁃
                    associated with variable levels of rifampin and rifabutin  dividualized treatment of drug⁃resistant spinal tuberculo⁃
                    resistance in Mycobacterium tuberculosis[J]. Infect Drug  sis[J]. Orthopedic Journal of China,2021,29(1):37-41
                    Resist,2022,15:6853-6861                     [40]FARZANEH S,NOROUZI F,FAZELI H,et al. Novel mu⁃
               [28]HUANG W J,LEE M K T,SIN A T K,et al. Evaluation of  tation in efflux pump Rv1258c(Tap)gene in drug resistant
                    Xpert MTB/RIF Ultra assay for detection of Mycobacteri⁃  clinical isolates of Mycobacterium tuberculosis in Iran[J]. J
                    um tuberculosis and rifampicin resistance[J]. Pathology,  Infect Dev Ctries,2024,18(2):243-250
                    2023,55(5):688-697                             (收稿:2025-10-14;修回:2025-12-20;录用:2025-12-30)
               [29]LEE Y,KIM S S,CHOI S M,et al. Rifamycin resistance,                          (本文编辑:陈汐敏)
   70   71   72   73   74   75   76   77   78   79   80